These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 339995)

  • 1. Rifampicin for lepromatous leprosy: nine years' experience.
    Waters MF; Rees RJ; Pearson JM; Laing AB; Helmy HS; Gelber RH
    Br Med J; 1978 Jan; 1(6106):133-6. PubMed ID: 339995
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Experimental and clinical studies on rifampicin in treatment of leprosy.
    Rees RJ; Pearson JM; Waters MF
    Br Med J; 1970 Jan; 1(5688):89-92. PubMed ID: 4903972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Resistance of Mycobacterium leprae to dapsone and rifampicin: apropos of a survey carried out in the Cape Verde region (Senegal)].
    Grosset J; Guelpa-Lauras CC; Millan J; Bodian M; Perani E
    Med Trop (Mars); 1987; 47(2):171-5. PubMed ID: 3306248
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rifampin therapy of lepromatous leprosy.
    Am J Trop Med Hyg; 1975 May; 24(3):475-84. PubMed ID: 1098495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of rifampicin and dapsone on experimental Mycobacterium leprae infections: minimum inhibitory concentrations and bactericidal action.
    Holmes IB; Hilson GR
    J Med Microbiol; 1972 May; 5(2):251-61. PubMed ID: 4555734
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone alone compared with dapsone plus rifampicin in short-term therapy of lepromatous leprosy.
    Gelber RH; Waters MF; Pearson JM; Rees RJ; McDougall AC
    Lepr Rev; 1977 Dec; 48(4):223-9. PubMed ID: 400806
    [No Abstract]   [Full Text] [Related]  

  • 7. Superiority of the neonatally thymectomized Lewis rat (NTLR) to monitor a clinical trial in lepromatous leprosy of the two regimens of rifampin and dapsone.
    Gelber RH; Humphres RC; Fieldsteel AH
    Int J Lepr Other Mycobact Dis; 1986 Jun; 54(2):273-83. PubMed ID: 3522770
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Resistance of Mycobacterium leprae to sulfones (DDS) and rifampicin in recurring lepromatous leprosy in Martinique and Guadeloupe since February 1980].
    Guelpa-Lauras CC; Constant-Desportes M; Millan J; Grosset J
    Acta Leprol; 1982; (86-87):77-80. PubMed ID: 6816000
    [No Abstract]   [Full Text] [Related]  

  • 9. Drug resistant leprosy--a comparison between proven dapsone and proven thiambutosine resistance.
    Waters MF; Pearson JM; Rees RJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):152-3. PubMed ID: 776850
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical and bacteriological effects of rifampicin in combination with L73A in leprosy: observation for six months.
    Innami S; Leguizamón OR; Alvarenga AE
    Lepr Rev; 1975 Jun; 46(2 Suppl):169-72. PubMed ID: 1100957
    [No Abstract]   [Full Text] [Related]  

  • 11. [Dynamics of establishing resistance of M. leprae to dapsone and rifampicin in Martinique].
    Constant-Desportes-Relouzat M; Grosset J; Guelpalauras CC; Salvini B; Cales-Quist D
    Acta Leprol; 1986; 4(3):293-300. PubMed ID: 3551468
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term treatment of dapsone-resistant leprosy with rifampicin: clinical and bacteriological studies.
    Rees RJ; Waters MF; Pearson JM; Helmy HS; Laing AB
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):159-69. PubMed ID: 776852
    [No Abstract]   [Full Text] [Related]  

  • 13. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
    Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
    Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clarithromycin is bactericidal against strains of Mycobacterium leprae resistant and susceptible to dapsone and rifampin.
    Walker LL; Van Landingham RM; Shinnick TM
    Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):59-65. PubMed ID: 8326182
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Persister M. leprae after introductory rifampicin followed by dapsone therapy.
    Sreevatsa ; Girdhar BK; Desikan KV
    Lepr India; 1981 Jul; 53(3):350-3. PubMed ID: 7278139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Once monthly rifampicin (1200 mg) plus daily dapsone (100 mg) and clofazimine (100 mg) in the initial treatment of lepromatous leprosy.
    Chandorkar AG; Burte NP; Gade RK; Bulakh PM
    Indian J Lepr; 1984; 56(1):63-70. PubMed ID: 6384381
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mycobacterium leprae persisters after treatment with dapsone and rifampicin.
    Pattyn SR; Dockx P; Rollier MT; Rollier R; Saerens EJ
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):154-8. PubMed ID: 776851
    [No Abstract]   [Full Text] [Related]  

  • 18. Intermittent rifampicin therapy in lepromatous leprosy.
    Girdhar BK; Sreevatsa ; Desikan KV
    Lepr India; 1980 Jan; 52(1):89-96. PubMed ID: 6991816
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Dapsone inhibition of the bactericidal action of rifampicin on Mycobacterium leprae in mice].
    Millan J; Moulia-Pelat JP
    Med Trop (Mars); 1989; 49(4):337-41. PubMed ID: 2695734
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Acedapsone (DADDS) treatment of leprosy patients in the Karimui of Papua New Guinea: status at six years.
    Russell DA; Shepard CC; McRae DH; Scott GC; Vincin DR
    Am J Trop Med Hyg; 1975 May; 24(3):485-95. PubMed ID: 1098496
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.